Skip to main content
. 2023 Mar 1;4(1):zpad015. doi: 10.1093/sleepadvances/zpad015

Table 1.

Baseline characteristics and medical comorbid conditions among study participants with OSA

Clinical parameters Patients
(n = 149)
Male
(n = 81)
Female
(n = 68)
P-value
Age (years) 48.89 (39.13, 57.08) 46.76 (38.08, 57.68) 49.7 (43.18, 56.3) 0.358
ASGS 3 (Regional) 108 (72%) 65 (80%) 43 (63%) 0.073
ASGS 4 (Remote) 10 (7%) 4 (5%) 6 (9%)
ASGS 5 (Very remote) 31 (21%) 12 (15%) 19 (28%)
Height (cm) 169 (163.03, 176) 175.5 (171, 178.5) 163 (157.15, 167) <0.001*
Weight (kg) 100.55 (88, 118.25) 104 (90, 115.95) 96.5 (84.5, 119) 0.328
BMI (kg/m2) 35.16 (30.72, 41.98) 34.3 (29.7, 39.29) 37.77 (31.72, 46.33) 0.002*
 Underweight (<18.5 kg/m2) 1 (1%) 0 (0%) 1 (2%) 0.004*
 Normal weight (18.5–24.9 kg/m2) 4 (3%) 3 (4%) 1 (2%)
 Overweight (25–29.9 kg/m2) 23 (16%) 19 (24%) 4 (6%)
 Obese (>30 kg/m2) 117 (81%) 57 (72%) 60 (91%)
Neck circumference (cm) 43 (41, 48) 45 (42, 48) 42.75 (39, 45) <0.001*
ESS 10 (6, 14) 10 (6, 14) 10 (8, 14) 0.476
Current smoker 97 (68%) 51 (65%) 46 (71%) 0.318
Former smoker 18 (13%) 8 (10%) 10 (15%)
Never smoker 27 (19%) 18 (23%) 9 (14%)
Ever alcohol 107 (75%) 60 (77%) 47 (72%) 0.527
Hypertension 69 (49%) 36 (47%) 33 (52%) 0.570
Heart disease 42 (30%) 22 (29%) 20 (31%) 0.729
Diabetes 41 (29%) 20 (26%) 21 (33%) 0.373
Dyslipidaemia 39 (28%) 19 (25%) 20 (31%) 0.385
Chronic Kidney disease 18 (13%) 7 (9%) 11 (17%) 0.206
COPD 15 (11%) 5 (6%) 10 (16%) 0.102
Hypothyroidism 9 (6%) 3 (4%) 6 (9%) 0.300
Time between diagnostic and CPAP (days) 54 (34, 115) 43 (31, 76) 74 (39, 189) 0.004*

P-value obtained via Kruskal–Wallis’s test (continuous parameters) or chi-squared test (categorical parameters) using Fishers exact test if categories had <10 patients.

Data displayed as median (IQR) or number (%).